MAb Explorations is involved in developing monoclonal antibodies for research and diagnostics. The company uses the classical Kohler and Milstein method as the anchor method for all pathogens of interest. The company focuses on the production of antibodies for diseases which currently lack treatment, such as Dengue and Enterovirus where there is a current unmet need and a potentially large market